Skip to content

New strategies to enhance photodynamic therapy for solid tumors

· 0 citations · 30 references

TL;DR

To assess the activation of survival pathways after PDT, human perihilar cholangiocarcinoma cells were subjected to PDT with zinc phthalocyanine-encapsulating liposomes and whole genome expression analysis was performed using Illumina HumanHT-12 v4 expression beadchips.

View source

Similar papers

Open access Aug 2026

Combination of 5-Aminolevulinic Acid and Indocyanine Green in Photodynamic Therapy for Squamous Cell Carcinoma: An In Vivo Study

The results indicated that the combined ALA+ICG-PDT approach produced the most sustained suppression of tumor growth and significantly prolonged animal survival compared with single-photosensitizer PDT, representing a promising strategy to enhance PDT efficacy for NMSC and other solid tumors.

A. Mahmood, Jeongwung Seo, M. B. Requena et al. · 0 citations
Review Open access Aug 2026

Photodynamic Therapy in Cancer: Mechanisms, Photosensitizer Technology, Vitamin Modulation, and Rational Combination Design

Overall, PDT combination design should be guided by whether adjunctive agents support or undermine photosensitizer accumulation, oxygen availability, ROS-mediated cytotoxicity, and immune activation, when selected according to mechanistic compatibility.

Ilaf Naser, D. Bartusik-Aebisher, Barbara Smolak et al. · 1 citation
Sep 2026

Two-photon photodynamic induction of PANoptosis and immunogenic cell death for precision tumor eradication using a dual-organelle-targeted STING agonist.

This study addresses triple-negative breast cancer treatment by developing a photosensitizer, DBC, with a multiple-twist molecular architecture, offering broader readers an impactful paradigm for engineering multi-functional biomaterials to combat aggressive cancers.

Hao Ren, Da-Lu Xie, Wen-Zhao Shang et al. · 0 citations
Sep 2026

Nanozyme-Driven Tumor Microenvironment Remodeling for Potentiated Phototherapy–Immunotherapy

A multifunctional manganese-based nanozyme loaded with indocyanine green (ICG) is developed to reprogram the immunosuppressive TME for potentiated phototherapy combined with immunotherapy and elicits robust immune memory to prevent recurrence and metastasis.

Chen-Lu Huang, Han-Yong Wang, Xin-Yu Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.